Citadel Advisors - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q2 2022$7,000
-78.8%
34,854
-24.3%
0.00%
Q2 2021$33,000
-70.8%
46,030
-65.7%
0.00%
Q1 2021$113,000
+2160.0%
134,256
+1015.5%
0.00%
Q4 2020$5,000
-86.1%
12,035
-87.8%
0.00%
Q3 2020$36,000
+227.3%
98,530
+352.5%
0.00%
Q1 2020$11,000
+83.3%
21,776
-15.6%
0.00%
Q4 2019$6,000
-75.0%
25,786
-74.1%
0.00%
Q3 2019$24,000
+100.0%
99,516
+63.3%
0.00%
Q3 2018$12,000
-7.7%
60,957
+0.2%
0.00%
Q2 2018$13,000
-72.9%
60,859
-59.4%
0.00%
Q1 2018$48,000
+585.7%
150,035
+298.7%
0.00%
Q4 2017$7,000
-74.1%
37,633
-75.9%
0.00%
Q3 2017$27,000
+237.5%
156,146
+374.2%
0.00%
Q2 2017$8,000
-33.3%
32,927
-29.4%
0.00%
Q1 2017$12,000
+200.0%
46,642
+189.5%
0.00%
Q4 2016$4,000
-81.0%
16,114
-81.5%
0.00%
Q2 2016$21,000
+425.0%
87,113
+220.9%
0.00%
Q4 2015$4,000
+100.0%
27,150
+149.9%
0.00%
Q3 2015$2,000
-86.7%
10,864
-74.1%
0.00%
Q2 2015$15,000
+150.0%
42,019
+73.8%
0.00%
Q3 2014$6,000
-82.9%
24,176
-73.6%
0.00%
Q2 2014$35,000
-39.7%
91,684
-20.6%
0.00%
Q1 2014$58,000
+286.7%
115,501
+162.3%
0.00%
Q4 2013$15,00044,0320.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q2 2015
NameSharesValueWeighting ↓
POPE ASSET MANAGEMENT, LLC 2,104,826$632,0000.51%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 1,290,463$387,0000.07%
GLENHILL ADVISORS LLC 200,000$60,0000.01%
Renaissance Technologies 136,300$41,0000.00%
Virtu KCG Holdings LLC 19,910$6,0000.00%
UBS Group AG 5,618$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders